CG Oncology, Inc.
SEC CIK 1991792 · CGON · last insider filing 2026-06-29
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Liu Brian Guan-Chyun | Director | filed 2024 - 2026 |
| Post Leonard E | Director | filed 2024 - 2026 |
| Mulay James | Director | filed 2024 - 2026 |
| Graf Susan E | Director | filed 2024 - 2026 |
| Rossi Christina | Director | filed 2025 - 2026 |
| Tong Victor Edward Jr | Director | filed 2024 - 2026 |
| Kuan Arthur | Director · Chief Executive Officer | filed 2024 - 2026 |
| Song Hong Fang | Director | filed 2024 - 2025 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Detore James M. | See Remarks | filed 2025 - 2026 |
| Patterson Joshua F. | See Remarks | filed 2024 - 2026 |
| Bellete Ambaw | President and COO | filed 2024 - 2026 |
| Kasturi Vijay | Chief Medical Officer | filed 2024 - 2026 |
| Lapetina Bob | See Remarks | filed 2025 - 2025 |
| Roche Corleen M. | CFO & Secretary | filed 2024 - 2025 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.